monsanto corp searl and unit said will report oper loss for 1987 main due expens for research and develop searl chairman sheldon gilgor said searl oper loss 1987 will less mln dlr oper loss 1986 said searl first quarter sale will pct 179 mln dlrs from 147 mln dlrs year ago quarter 1986 searl sale were 665 mln dlrs gilgor said compani intend have sale three billion dlrs mid 1990s said compani anticip approv japan itali spain and for it ulcer treatment drug cytotech also said paper not yet publish drug was prevent flare ulcer for longer period time tagamet made smithklin beckman corp drug searl pipelin includ tissu plasminogen activ tpa made differ process genentech tpa expect approv for market this year reuter 